Literature DB >> 20686823

The eighth American college of chest physicians guidelines on venous thromboembolism prevention: implications for hospital prophylaxis strategies.

Michael H Huo1, Alex C Spyropoulos.   

Abstract

Venous thromboembolism (VTE) is the most common potentially preventable form of hospital-related mortality. It presents as a major healthcare burden, affecting both medical and surgical patients. The prevention of VTE has been identified as one of the most important in-hospital safety practices in the US. VTE guideline recommendations provide a framework for clinical practice and guide VTE prophylaxis policies. Guidelines produced by the American College of Chest Physicians (ACCP) are considered to be the 'gold standard' in VTE prevention, diagnosis and management, and have been updated. A number of differences exist between the new 2008 ACCP guidelines on VTE prevention and the previous version published in 2004. There are variations regarding VTE prevention, including new and stronger evidence-based recommendations for several indications and agents. The updated guidelines give a strong recommendation that every hospital develop a VTE prevention policy, which is particularly important given the current international drive to reduce the incidence of VTE. A formal hospital policy should help improve compliance with appropriate VTE prophylaxis strategies. The ACCP guidelines form a basis for improving patient safety at a time of public reporting of quality of care, hospital accreditation, national standards of care, and pay for performance initiatives. In this review, changes in recommendations for VTE prevention in the 2008 ACCP guidelines compared with the previous edition in 2004 are outlined. In addition, outstanding areas of debate are discussed and the role of the 2008 ACCP guidelines in the context of the new VTE performance measures analyzed.

Entities:  

Mesh:

Year:  2011        PMID: 20686823     DOI: 10.1007/s11239-010-0500-6

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  45 in total

1.  Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial.

Authors:  Alexander T Cohen; Bruce L Davidson; Alexander S Gallus; Michael R Lassen; Martin H Prins; Witold Tomkowski; Alexander G G Turpie; Jan F M Egberts; Anthonie W A Lensing
Journal:  BMJ       Date:  2006-01-26

Review 2.  A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals.

Authors:  Rebecca Tooher; Philippa Middleton; Clarabelle Pham; Robert Fitridge; Siohban Rowe; Wendy Babidge; Guy Maddern
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

Review 3.  Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.

Authors:  R D Hull; G F Pineo; P D Stein; A F Mah; S M MacIsaac; O E Dahl; M Butcher; R F Brant; W A Ghali; D Bergqvist; G E Raskob
Journal:  Ann Intern Med       Date:  2001-11-20       Impact factor: 25.391

4.  Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data.

Authors:  N Levitan; A Dowlati; S C Remick; H I Tahsildar; L D Sivinski; R Beyth; A A Rimm
Journal:  Medicine (Baltimore)       Date:  1999-09       Impact factor: 1.889

5.  Thromboprophylaxis in medically ill patients at risk for venous thromboembolism.

Authors:  Edward Burleigh; Cheng Wang; David Foster; Sivana Heller; Dennis Dunn; Kaveh Safavi; Brian Griffin; Jeff Smith
Journal:  Am J Health Syst Pharm       Date:  2006-10-15       Impact factor: 2.637

6.  Twice vs three times daily heparin dosing for thromboembolism prophylaxis in the general medical population: A metaanalysis.

Authors:  Christopher S King; Aaron B Holley; Jeffrey L Jackson; Andrew F Shorr; Lisa K Moores
Journal:  Chest       Date:  2007-02       Impact factor: 9.410

7.  Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism.

Authors:  Victor F Tapson; Hervé Decousus; Mario Pini; Beng H Chong; James B Froehlich; Manuel Monreal; Alex C Spyropoulos; Geno J Merli; Rainer B Zotz; Jean-François Bergmann; Ricardo Pavanello; Alexander G G Turpie; Mashio Nakamura; Franco Piovella; Ajay K Kakkar; Frederick A Spencer; Gordon Fitzgerald; Frederick A Anderson
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

8.  Electronic alerts to prevent venous thromboembolism among hospitalized patients.

Authors:  Nils Kucher; Sophia Koo; Rene Quiroz; Joshua M Cooper; Marilyn D Paterno; Boris Soukonnikov; Samuel Z Goldhaber
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

Review 9.  American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients?

Authors:  John W Eikelboom; Ganesan Karthikeyan; Nick Fagel; Jack Hirsh
Journal:  Chest       Date:  2009-02       Impact factor: 9.410

10.  Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism.

Authors:  Frederick A Anderson; Maxim Zayaruzny; John A Heit; Dogan Fidan; Alexander T Cohen
Journal:  Am J Hematol       Date:  2007-09       Impact factor: 10.047

View more
  6 in total

1.  Safety and Efficacy of an Absorbable Filter in the Inferior Vena Cava to Prevent Pulmonary Embolism in Swine.

Authors:  Steven Y Huang; Mitchell Eggers; Mark J McArthur; Katherine A Dixon; Amanda McWatters; Stephen Dria; Lori R Hill; Marites P Melancon; Joseph R Steele; Michael J Wallace
Journal:  Radiology       Date:  2017-07-14       Impact factor: 11.105

2.  Fondaparinux Sodium Compared With Low-Molecular-Weight Heparins for Perioperative Surgical Thromboprophylaxis: A Systematic Review and Meta-analysis.

Authors:  Arun Kumar; Ashna Talwar; Joel F Farley; Jagannath Muzumdar; Jon C Schommer; Rajesh Balkrishnan; Wenchen Wu
Journal:  J Am Heart Assoc       Date:  2019-05-21       Impact factor: 5.501

3.  Advances in oral anticoagulation treatment: the safety and efficacy of rivaroxaban in the prevention and treatment of thromboembolism.

Authors:  Alexander G G Turpie
Journal:  Ther Adv Hematol       Date:  2012-10

4.  Hospital out-lying through lack of beds and its impact on care and patient outcome.

Authors:  Andrew Stowell; Pierre-Geraud Claret; Mustapha Sebbane; Xavier Bobbia; Charlotte Boyard; Romain Genre Grandpierre; Alexandre Moreau; Jean-Emmanuel de La Coussaye
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2013-03-14       Impact factor: 2.953

Review 5.  Neuraxial and peripheral nerve blocks in patients taking anticoagulant or thromboprophylactic drugs: challenges and solutions.

Authors:  Jinlei Li; Thomas Halaszynski
Journal:  Local Reg Anesth       Date:  2015-08-04

6.  Rate of venous thromboembolism among surgical patients in Australian hospitals: a multicentre retrospective cohort study.

Authors:  Hassan Assareh; Jack Chen; Lixin Ou; Stephanie J Hollis; Kenneth Hillman; Arthas Flabouris
Journal:  BMJ Open       Date:  2014-10-03       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.